SIRT6 and cancer: Given the double-facedinvolvementof SIRT6 in cancer and inflammation, inhibition of SIRT6 in specificcontexts may represent a successful strategy for cancer management.Indeed, inhibitors may target different SIRT6-mediated pathways thatcontribute to cancer progression such as DNA repair mechanisms, celldifferentiation inhibition, and inflammatory response (Table 2).